This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Denali Therapeutics Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Yashas Rajendra: Innovator in Protein Therapeutics
Introduction
Yashas Rajendra is a notable inventor based in San Mateo, CA (US). He has made significant contributions to the field of protein therapeutics, particularly in the treatment of rare diseases. His innovative work focuses on developing proteins that can effectively cross the blood-brain barrier.
Latest Patents
Yashas Rajendra holds a patent for "Fusion proteins comprising acid alpha-glucosidase enzymes and methods thereof." This patent describes proteins capable of being transported across the blood-brain barrier and includes an acid alpha-glucosidase (GAA) enzyme-Fc fusion polypeptide. The methods outlined in this patent aim to treat Pompe disease, a rare genetic disorder.
Career Highlights
Currently, Yashas Rajendra is associated with Denali Therapeutics Inc., where he continues to advance his research in protein therapeutics. His work is pivotal in developing treatments that can improve the quality of life for patients suffering from genetic disorders.
Collaborations
Yashas collaborates with talented individuals such as Mihalis S Kariolis and Melina Lenser. These partnerships enhance the innovative efforts within his research team, fostering a collaborative environment that drives scientific discovery.
Conclusion
Yashas Rajendra's contributions to the field of protein therapeutics exemplify the impact of innovation in medicine. His work not only advances scientific knowledge but also holds the potential to transform treatment options for patients with rare diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile